Covered Outpatient Drugs Final Rule Series Part 1: Implications for GP Professionals
The Final Rule on Covered Outpatient Drugs was finally released by the Centers for Medicare and Medicaid Services (CMS) on Jan 21, 2016. In this webinar, Huron Managing Director Chris Cobourn and Senior Director Clay Willis, along with Joe Metro of Reed Smith, provided an in-depth review of the CMS AMP Final Rule and commentary, along with insights into the ramifications for manufacturers.
The key topics were:
- What it will take to implement the Final Rule
- Key elements of the Final Rule
- Potential impacts the Final Rule will have on the industry
This webinar is the first in a series of events that Huron will be hosting before the Apr 1, 2016 implementation deadline. To receive Huron's updates to your inbox, subscribe to our email list.
You can also hear more from Huron on this issue by following @Huron on Twitter for up-to-date webinar, events, and speaking engagements, and/or subscribing to our weekly newsletter on topical research compliance news.Read More